<DOC>
	<DOCNO>NCT01289418</DOCNO>
	<brief_summary>Influenza vaccine continuously modify adjust virus antigenic shift drift , safety profile may vary . While generally consider safe , influenza vaccine associate past increase case Guillain-Barr√© syndrome ( 1976 ) oculorespiratory syndrome ( 2001 ) . The emergence novel strain H1N1 influenza virus ( pH1N1 ) prompt health department worldwide prepare mass vaccination campaign new H1N1 pandemic vaccine . Following recommendation World Health Organization ( WHO ) , Canada immunize population dose-sparing adjuvanted vaccine . While adjuvant developed GlaxoSmithKline ( GSK ) administer 39 000 people , hundred vaccinated H1N1 formulation clinical trial mass campaign launch . With small number , adverse event occur rate &lt; 1 % detected clinical trial . Considering case pH1N1 date relatively mild , imperative rapidly detect adverse event serious enough reconsider use vaccine . Passive surveillance collect notification adverse event sensitivity system high timeliness necessarily optimal . In Canada , healthcare worker ( HCW ) among offer new pandemic vaccine priority . Because offer vaccine early campaign constitute well-defined group good general health , group people may well suit monitor safety pH1N1 vaccine . The main objective project estimate HCW vaccinate pH1N1 frequency adverse event sufficient severity cause work absenteeism medical consultation . The active surveillance do HCW 3 site ( Canadian hospital ) participate Pandemic Influenza Research Network ( PCIRN ) : ( 1 ) Halifax ( Nova Scotia ) , ( 2 ) Quebec City ( Quebec ) : 3 hospital , ( 3 ) Toronto</brief_summary>
	<brief_title>Surveillance Adverse Events Following Pandemic H1N1 Immunization</brief_title>
	<detailed_description />
	<criteria>To health care worker one three Canadian Hospitals participate Public Health Agency Canada/Canadian Institutes Health Research Influenza Research Network ( PCIRN ) : Quebec City , Toronto , Halifax . To immunized pH1N1 vaccine . To email address . To 18 year old old .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>H1N1</keyword>
	<keyword>vaccine safety</keyword>
	<keyword>adverse event</keyword>
	<keyword>health care worker</keyword>
</DOC>